Dr. Gregory Larkin, MD

NPI: 1205890084
Total Payments
$2,451
2023 Payments
$976.39
Companies
6
Transactions
8
Medicare Patients
320
Medicare Billing
$40,512

Payment Breakdown by Category

Consulting$1,550 (63.2%)
Other$500.00 (20.4%)
Food & Beverage$400.73 (16.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $1,550 2 63.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $500.00 1 20.4%
Food and Beverage $400.73 5 16.4%

Top Paying Companies

Company Total Records Latest Year
Quidel Corporation $800.00 1 $0 (2023)
Abbott Laboratories $750.00 1 $0 (2022)
Philips Electronics North America Corporation $500.00 1 $0 (2018)
AstraZeneca Pharmaceuticals LP $224.34 2 $0 (2022)
ABBVIE INC. $148.89 2 $0 (2023)
E.R. Squibb & Sons, L.L.C. $27.50 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $976.39 4 Quidel Corporation ($800.00)
2022 $866.03 2 Abbott Laboratories ($750.00)
2021 $108.31 1 AstraZeneca Pharmaceuticals LP ($108.31)
2018 $500.00 1 Philips Electronics North America Corporation ($500.00)

All Payment Transactions

8 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/28/2023 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $27.50 General
Category: Cardiovascular
09/21/2023 ABBVIE INC. DALVANCE (Drug) Food and Beverage In-kind items and services $125.00 General
Category: ANTI-INFECTIVE
09/14/2023 Quidel Corporation Consulting Fee Cash or cash equivalent $800.00 General
04/21/2023 ABBVIE INC. AVYCAZ (Drug) Food and Beverage In-kind items and services $23.89 General
Category: ANTI-INFECTIVE
12/07/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $116.03 General
Category: Rare Disease
04/15/2022 Abbott Laboratories I-STAT (Device) Consulting Fee Cash or cash equivalent $750.00 General
Category: Rapid Diagnostics
03/08/2021 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $108.31 General
Category: Cardiovascular and Metabolism
10/01/2018 Philips Electronics North America Corporation Lumify (Device), Sparq Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $500.00 General
Category: Cardiology/Vascular Diseases

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 79 81 $111,193 $10,247
2022 4 69 70 $26,035 $7,499
2021 3 61 62 $72,813 $8,936
2020 4 111 113 $107,780 $13,831
Total Patients
320
Total Services
326
Medicare Billing
$40,512
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 55 57 $87,019 $7,931 9.1%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 24 24 $24,174 $2,316 9.6%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 16 17 $6,881 $2,477 36.0%
99291 Critical care, first 30-74 minutes Facility 2022 13 13 $8,650 $2,221 25.7%
99284 Emergency department visit for problem of high severity Facility 2022 18 18 $7,260 $1,576 21.7%
99283 Emergency department visit for problem of moderate severity Facility 2022 22 22 $3,244 $1,224 37.7%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 16 17 $28,809 $3,428 11.9%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 19 19 $22,338 $3,122 14.0%
99284 Emergency department visit, problem of high severity Facility 2021 26 26 $21,665 $2,385 11.0%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 28 28 $37,980 $5,784 15.2%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 24 24 $27,806 $3,723 13.4%
99284 Emergency department visit, problem of high severity Facility 2020 33 34 $30,199 $3,159 10.5%
99283 Emergency department visit, moderately severe problem Facility 2020 26 27 $11,796 $1,164 9.9%

About Dr. Gregory Larkin, MD

Dr. Gregory Larkin, MD is a Emergency Medicine healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205890084.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Larkin, MD has received a total of $2,451 in payments from pharmaceutical and medical device companies, with $976.39 received in 2023. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($1,550).

As a Medicare-enrolled provider, Larkin has provided services to 320 Medicare beneficiaries, totaling 326 services with total Medicare billing of $40,512. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Location New Haven, CT
  • Active Since 04/17/2006
  • Last Updated 02/10/2017
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1205890084

Products in Payments

  • I-STAT (Device) $750.00
  • Lumify (Device) $500.00
  • DALVANCE (Drug) $125.00
  • ANDEXXA (Biological) $116.03
  • LOKELMA (Drug) $108.31
  • CAMZYOS (Drug) $27.50
  • AVYCAZ (Drug) $23.89

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in New Haven